744 IN VIVO AND IN VITRO RESISTANCE TO SILIBININ, A COMPONENT OF SILYMARIN AND POTENT INHIBITOR OF HCV REPLICATION

MLA

Thomas-Matthias Scherzer, et al. “744 in Vivo and in Vitro Resistance to Silibinin, a Component of Silymarin and Potent Inhibitor of Hcv Replication.” Journal of Hepatology, vol. 52, Apr. 2010, pp. S289–90. EBSCOhost, https://doi.org/10.1016/s0168-8278(10)60746-5.

APA

Thomas-Matthias Scherzer, Rozenn Brillet, Alexandre Soulier, Peter Ferenci, K. Zinober, J.-M. Pawlotsky, Abdelhakim Ahmed-Belkacem, & Stéphane Chevaliez. (2010). 744 in Vivo and in Vitro Resistance to Silibinin, a Component of Silymarin and Potent Inhibitor of Hcv Replication. Journal of Hepatology, 52, S289–S290. https://doi.org/10.1016/s0168-8278(10)60746-5

Chicago

Thomas-Matthias Scherzer, Rozenn Brillet, Alexandre Soulier, Peter Ferenci, K. Zinober, J.-M. Pawlotsky, Abdelhakim Ahmed-Belkacem, and Stéphane Chevaliez. 2010. “744 in Vivo and in Vitro Resistance to Silibinin, a Component of Silymarin and Potent Inhibitor of Hcv Replication.” Journal of Hepatology 52 (April): S289–90. doi:10.1016/s0168-8278(10)60746-5.